{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:42:23Z","timestamp":1788550943667,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.amjmed.2005.08.043","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T07:10:13Z","timestamp":1143529813000},"page":"355.e15-355.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Diagnostic Performance of 123I-Labeled Serum Amyloid P Component Scintigraphy in Patients with Amyloidosis"],"prefix":"10.1016","volume":"119","author":[{"given":"Bouke P.C.","family":"Hazenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"van Rijswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Albertus","family":"Piers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn N.","family":"Lub-de Hooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Haagsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter L.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.08.043_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/13506129709003838","article-title":"Amyloid P component","volume":"4","author":"Pepys","year":"1997","journal-title":"Amyloid"},{"key":"10.1016\/j.amjmed.2005.08.043_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI114917","article-title":"Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis","volume":"86","author":"Hawkins","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2005.08.043_bib6","first-page":"365","article-title":"Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression","volume":"86","author":"Hawkins","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/qjmed\/90.1.45","article-title":"\u2018Localized amyloidosis\u2019","volume":"90","author":"Maulin","year":"1997","journal-title":"Q J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002590050273","article-title":"Serum amyloid P component scintigraphy in familial amyloid polyneuropathy","volume":"25","author":"Rydh","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9343(94)00054-9","article-title":"Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy","volume":"101","author":"Hachulla","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib10","first-page":"121","article-title":"Diagnostic and therapeutic approach of systemic amyloidosis","volume":"62","author":"Hazenberg","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib11","first-page":"45","article-title":"Primary systemic amyloidosis","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/j.amjmed.2005.08.043_bib12","first-page":"699","article-title":"Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value","volume":"39","author":"Jager","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib13","first-page":"376","article-title":"Systemic amyloidosis","volume":"29","author":"Janssen","year":"1986","journal-title":"Neth J Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib14","first-page":"37","article-title":"Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis","volume":"53","author":"Snow","year":"1985","journal-title":"Lab Invest"},{"key":"10.1016\/j.amjmed.2005.08.043_bib15","series-title":"Amyloid and Amyloidosis 1993","first-page":"685","article-title":"Comparison of histology with SAP scintigraphy for evaluation of amyloidosis","author":"Vigushin","year":"1994"},{"key":"10.1016\/j.amjmed.2005.08.043_bib16","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2005.08.043_bib17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2005.08.043_bib18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(88)92235-0","article-title":"Diagnostic radionuclide imaging of amyloid","volume":"1","author":"Hawkins","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.08.043_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s002590050272","article-title":"Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis","volume":"25","author":"Hawkins","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.1780360616","article-title":"Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis","volume":"36","author":"Hawkins","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2005.08.043_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.08.043_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/95.4.211","article-title":"Unicentric Castleman\u2019s disease complicated by systemic AA amyloidosis","volume":"95","author":"Lachmann","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.amjmed.2005.08.043_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13506120209114818","article-title":"AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation","volume":"9","author":"van Gameren","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.amjmed.2005.08.043_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2005.08.043_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gut.42.5.727","article-title":"The liver in systemic amyloidosis","volume":"42","author":"Lovat","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2005.08.043_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ki.1990.329","article-title":"Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131-I-\u03b22-microglobulin","volume":"38","author":"Floege","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2005.08.043_bib27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","article-title":"Cardiac and pleuropulmonary AL amyloid imaging with technetium-99-m labelled aprotinin","volume":"22","author":"Aprile","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00998166","article-title":"Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis","volume":"16","author":"Janssen","year":"1990","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.amjmed.2005.08.043_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","article-title":"99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy","volume":"29","author":"Puille","year":"2002","journal-title":"Eur J Nucl Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305007874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305007874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:40:28Z","timestamp":1757580028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305007874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002934305007874"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.08.043","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Performance of 123I-Labeled Serum Amyloid P Component Scintigraphy in Patients with Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}